Alzheimer’s disease markers from structural MRI and FDG-PET brain images

Andrea Chincarini, Paolo Bosco, Gianluca Gemme, Silvia Morbelli, Dario Arnaldi, Francesco Sensi, Ilaria Solano, Nicola Amoroso, Sabina Tangaro, Renata Longo, Sandro Squarcia, Flavio Nobili

Research output: Contribution to journalArticlepeer-review


Despite the widespread use of neuroimaging tools (morphological and functional) in the routine diagnostic of cerebral diseases, the information available by the end user -the clinician- remains largely limited to qualitative visual analysis. This restriction greatly reduces the diagnostic impact of neuroimaging in routine clinical practice and increases the risk of misdiagnosis. In this context, researches are focussing on the development of sophisticated automatic analyses able to extract clinically relevant information from the captured data. The identification of biological markers at early stages of Alzheimer’s disease (AD) contributes to diagnostic accuracy and adds prognostic value. However, in spite of recent developments, results of structural and functional imaging studies on predicting conversion to AD are not uniform. We provide here an overview of analysis methods and approaches, discussing their contribution to clinical assessment.

Original languageEnglish
Article number135
JournalEuropean Physical Journal Plus
Issue number11
Publication statusPublished - Nov 1 2012

ASJC Scopus subject areas

  • Physics and Astronomy(all)


Dive into the research topics of 'Alzheimer’s disease markers from structural MRI and FDG-PET brain images'. Together they form a unique fingerprint.

Cite this